Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trialAlexandra Gilbert, Vicky Goh, M. Hawkins et al.|The Lancet Oncology|2025Cited by 23
Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) – study protocol paper for a phase III multicentre, open-label randomised controlled trialFinbar Slevin, Ann Henry, S. Alexander et al.|BMJ Open|2024Cited by 12
Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma (BRIOChe) – protocol for a multi-centre open-label randomised trialEleanor Hudson, Louise Murray, Samantha Noutch et al.|BMJ Open|2024Cited by 9
Personalising anal cancer radiotherapy dose (PLATO): protocol for a multicentre integrated platform trialRussell Frood, David Sebag‐Montefiore, Alexandra Gilbert et al.|BMJ Open|2025Cited by 8
3665 PLATO ACT 4: Long term results of an RCT evaluating reduced dose and standard dose chemoradiotherapy in early-stage anal cancer (ISRCTN:88455282)David Sebag‐Montefiore, Richard Adams, Mark Harrison et al.|Radiotherapy and Oncology|2025Cited by 1